June 19, 2018

A few weeks ago we were  discussing DNA testing and the value this will have in medication choices. This week Steve shares an interview he had with Dr. Jeffrey Mechanick on a topic similar to our DNA discussion as they work their way through transcultural endocrinology and how this new way of looking at diabetes will likely define therapy choices for years to come.

Dave Joffe

Editor-in-chief